StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Siddharth Sedani, Anand Rathi

BUYRainbow Childrens Medicare Limited

bySiddharth Sedani, Anand RathiHorizon: 1 year28 Sept 2026via Zee Business (Live)

Entry₹1,374.8Inferred
Target₹1,750
Total upside +27.29%
Stop lossNot given
CMP₹1,373.4Just now
Active-0.10%+27.42%upside left 12 mo left
Follow Siddharth Sedani for new callsGet alertsWatch RAINBOW for new buy/sell callsGet alertsSee 5 other Long-term calls on RAINBOWSee 61 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Sept, 2:37 pm IST
14 supporting2 neutral1 opposing
Supports the BUY call (14)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·28 Sept · yesterday

Rainbow Children's Medicare Ltd appointed Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) and addressed other general matters during its Board Meeting.

BSE · Others·23 Sept · 5d ago

(opens in new tab)

Mr. Sudarshan Patodia has been appointed as the Chief Financial Officer (KMP) of the company.

BSE · Company Update·23 Sept · 5d ago

(opens in new tab)

Mr. Sudarshan Patodia appointed as Chief Financial Officer of the company effective September 23, 2026.

NSE · Appointment·23 Sept · 5d ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·16 Sept · 2w ago

Neutral / worth noting (2)

Rainbow Children's Medicare Limited announced the appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (CFO) and Key Managerial Personnel, effective September 23, 2026. The board also a

NSE · Outcome of Board Meeting·23 Sept · 5d ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.